Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-25 | “Dr. Xu received a B.S. in biochemistry ... and a Ph.D. in biochemistry...” |
| 2023-04-21 | "Dr. Xu received a B.S. in biochemistry... and a Ph.D. in biochemistry... and she completed her postdoctoral training in virology and gene therapy" |
| 2024-04-26 | "Dr. Xu received a B.S. in biochemistry... and a Ph.D. in biochemistry... and she completed her postdoctoral training in virology and gene therapy" |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-04